DAVID N. GILL

Insider Reports History

Location
Newport Beach, CA
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DAVID N. GILL:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evolus, Inc. Director Common Stock 41,328 $448,487 $10.85 07 Mar 2025 Direct
Y-mAbs Therapeutics, Inc. Director Common Stock 0 $0 $8.52 16 Sep 2025 Direct
Evolus, Inc. Director Stock Option (Right to Buy) 11,146 07 Mar 2025 Direct
Strongbridge Biopharma plc Director Ordinary Shares 0 $2.06 05 Oct 2021 Direct
Y-mAbs Therapeutics, Inc. Director Employee Stock Option (right to buy) 0 16 Sep 2025 Direct

Insider Reports Filed by DAVID N. GILL

Symbol Company Period Transactions Value $ Form Type Role Filing Time
YMAB Y-mAbs Therapeutics, Inc. 16 Sep 2025 10 -$50,095 4 Director 18 Sep 2025, 21:27
YMAB Y-mAbs Therapeutics, Inc. 30 Jun 2025 2 $0 4 Director 02 Jul 2025, 16:20
EOLS Evolus, Inc. 07 Mar 2025 2 $0 4 Director 11 Mar 2025, 18:54
YMAB Y-mAbs Therapeutics, Inc. 11 Jun 2024 2 $0 4 Director 13 Jun 2024, 21:00
EOLS Evolus, Inc. 13 May 2024 2 -$131,010 4 Director 15 May 2024, 17:20
EOLS Evolus, Inc. 07 Feb 2024 2 $0 4 Director 09 Feb 2024, 18:37
YMAB Y-mAbs Therapeutics, Inc. 08 Jun 2023 2 $0 4 Director 09 Jun 2023, 18:01
EOLS Evolus, Inc. 27 Jan 2023 2 $0 4 Director 31 Jan 2023, 19:41
YMAB Y-mAbs Therapeutics, Inc. 15 Jul 2022 1 $0 4 Director 19 Jul 2022, 13:20
EOLS Evolus, Inc. 13 May 2022 2 -$137,664 4 Director 17 May 2022, 18:49
EOLS Evolus, Inc. 24 Jan 2022 2 $0 4 Director 26 Jan 2022, 20:01
/report/000117911021009277-gill-david-n-2021-10-05 Strongbridge Biopharma plc 05 Oct 2021 1 $0 4 Director 06 Oct 2021, 19:41
/report/000117911021009218-gill-david-n-2021-10-01 Strongbridge Biopharma plc 01 Oct 2021 1 -$36,592 4 Director 05 Oct 2021, 19:21
YMAB Y-mAbs Therapeutics, Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:03
/report/000117911021005555-gill-david-n-2021-05-18 Strongbridge Biopharma plc 18 May 2021 1 $0 4 Director 18 May 2021, 19:10
/report/000117911021005441-gill-david-n-2021-05-14 Strongbridge Biopharma plc 14 May 2021 1 -$44,826 4 Director 17 May 2021, 18:29